LSL Pharma Group Statistics
Total Valuation
TSXV:LSL has a market cap or net worth of CAD 44.48 million. The enterprise value is 65.82 million.
Market Cap | 44.48M |
Enterprise Value | 65.82M |
Important Dates
The last earnings date was Thursday, May 22, 2025.
Earnings Date | May 22, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
TSXV:LSL has 115.53 million shares outstanding. The number of shares has increased by 43.56% in one year.
Current Share Class | 115.53M |
Shares Outstanding | 115.53M |
Shares Change (YoY) | +43.56% |
Shares Change (QoQ) | +18.45% |
Owned by Insiders (%) | 24.54% |
Owned by Institutions (%) | n/a |
Float | 79.05M |
Valuation Ratios
The trailing PE ratio is 12.83.
PE Ratio | 12.83 |
Forward PE | n/a |
PS Ratio | 2.51 |
PB Ratio | 1.79 |
P/TBV Ratio | 3.88 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 34.37, with an EV/FCF ratio of -20.25.
EV / Earnings | 19.84 |
EV / Sales | 3.71 |
EV / EBITDA | 34.37 |
EV / EBIT | 162.12 |
EV / FCF | -20.25 |
Financial Position
The company has a current ratio of 1.59, with a Debt / Equity ratio of 0.87.
Current Ratio | 1.59 |
Quick Ratio | 0.54 |
Debt / Equity | 0.87 |
Debt / EBITDA | 11.30 |
Debt / FCF | -6.66 |
Interest Coverage | 0.21 |
Financial Efficiency
Return on equity (ROE) is 19.78% and return on invested capital (ROIC) is 0.71%.
Return on Equity (ROE) | 19.78% |
Return on Assets (ROA) | 0.60% |
Return on Invested Capital (ROIC) | 0.71% |
Return on Capital Employed (ROCE) | 0.93% |
Revenue Per Employee | 155,684 |
Profits Per Employee | 29,096 |
Employee Count | 186 |
Asset Turnover | 0.42 |
Inventory Turnover | 1.88 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -25.49% in the last 52 weeks. The beta is -0.50, so TSXV:LSL's price volatility has been lower than the market average.
Beta (5Y) | -0.50 |
52-Week Price Change | -25.49% |
50-Day Moving Average | 0.36 |
200-Day Moving Average | 0.40 |
Relative Strength Index (RSI) | 52.67 |
Average Volume (20 Days) | 34,891 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TSXV:LSL had revenue of CAD 17.75 million and earned 3.32 million in profits. Earnings per share was 0.03.
Revenue | 17.75M |
Gross Profit | 5.35M |
Operating Income | 406,000 |
Pretax Income | 3.37M |
Net Income | 3.32M |
EBITDA | 1.71M |
EBIT | 406,000 |
Earnings Per Share (EPS) | 0.03 |
Balance Sheet
The company has 296,000 in cash and 21.64 million in debt, giving a net cash position of -21.34 million or -0.18 per share.
Cash & Cash Equivalents | 296,000 |
Total Debt | 21.64M |
Net Cash | -21.34M |
Net Cash Per Share | -0.18 |
Equity (Book Value) | 24.89M |
Book Value Per Share | 0.22 |
Working Capital | 5.72M |
Cash Flow
In the last 12 months, operating cash flow was -1.65 million and capital expenditures -1.60 million, giving a free cash flow of -3.25 million.
Operating Cash Flow | -1.65M |
Capital Expenditures | -1.60M |
Free Cash Flow | -3.25M |
FCF Per Share | -0.03 |
Margins
Gross margin is 30.13%, with operating and profit margins of 2.29% and 18.69%.
Gross Margin | 30.13% |
Operating Margin | 2.29% |
Pretax Margin | 18.97% |
Profit Margin | 18.69% |
EBITDA Margin | 9.61% |
EBIT Margin | 2.29% |
FCF Margin | n/a |
Dividends & Yields
TSXV:LSL does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -43.56% |
Shareholder Yield | n/a |
Earnings Yield | 7.46% |
FCF Yield | -7.31% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
TSXV:LSL has an Altman Z-Score of 1.09. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.09 |
Piotroski F-Score | n/a |